Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in glucose tolerance in people with cystic fibrosis after initiation of first-generation CFTR modulator treatment.

Pediatric pulmonology - 1 Sept 2023

Ekblond Rikke Spragge, Nielsen Bibi Uhre, Højte Christine, Almdal Thomas Peter, Shaw James, Pressler Tacjana, Faurholt-Jepsen Daniel, Mathiesen Inger Hee Mabuza

Abstract excerpt

BACKGROUND: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have been shown to have a beneficial effect on pulmonary function and nutritional status in patients with cystic fibrosis (CF), but the extent to which they affect glucose tolerance is not fully understood. In the current study, we evaluated the change in glucose tolerance and insulin secretion after first-generation CFTR modulator...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Benzodioxoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C-Peptide

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Glucose

Share to Glycated Hemoglobin

Share to Insulin Resistance

Source

Identifiers

PMID: 37341613
DOI: 10.1002/ppul.26562

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in glucose tolerance in people with cystic fibrosis after initiation of first-generation CFTR modulator treatment.PMID 37341613Read ↗

Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis.Semantic proximity Read ↗

Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion.Semantic proximity Read ↗

Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort: Short title: Decline in HbA1c after elexacaftor/tezacaftor/ivacaftor treatment.Semantic proximity Read ↗

Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/Ivacaftor.Semantic proximity Read ↗

Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes.Semantic proximity Read ↗

Carbohydrate metabolism changes in cystic fibrosis.Semantic proximity Read ↗

Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.Semantic proximity Read ↗

Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients.Semantic proximity Read ↗

One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational StudySemantic proximity Read ↗

Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor.Semantic proximity Read ↗

CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation.Semantic proximity Read ↗

Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.